Table 1 . Characteristics of studies included in the HBV prevalence meta-analysis in the general Iranian population .

Code	First Author	Year	Province	Sample Size	Age Range	Hbs Ag Prevalence (%) “Total”	Hbs Ag Prevalence (%) “Male”	HbsAg Prevalence (%) “Female”
1	Bayat 21	2000	Azarbayjan sharghi	4207	*NR	1.2	*NR	*NR
2	Hasan Zade 22	1997	Azarbayjan sharghi	3409	2-69	2.9	3.5	2.5
3	Abdolahi 23	2004	Golestan	1850	25-65	8.86	10.8	8.6
4	Merat 7	2007	Golestan	1896	18-65	5.1	5.4	4.8
5	Jamali 24	2006	Golestan	2049	18-75	5.0	5.4	4.7
6	Amini 25	*NR	Hamedan	4930	*NR	2.49	*NR	*NR
7	Alizade 26	2001	Hamedan	1824	6-93	2.3	*NR	*NR
8	Merat 7	2007	Hormozgan	1455	18-65	2.7	3.4	2.0
9	Nokhodiyan 27	2005	Isfahan	816	6-Max	1.3	1.8	7.0
10	Farhat 28	1997	Khorasan	4528	2-100	3.6	*NR	*NR
11	Shakeri 29	2010	Khorasan Razavi	3198	15-65	1.0	1.6	0.7
12	Fathi-Moghadam 30	2009	Khorasan Razavi	1678	1-90	1.39	2.0	0.89
13	Alavian 31	*NR	Kurdistan	1613	6-65	0.87	1.1	0.75
14	Ali Papi 32	2013	Lorestan	454	*NR	5.9	6.2	5.7
15	Zali 6	1990	National Survey	39841	2-69	1.7	1.9	1.5
16	Zali 9	1998	National Survey	46631	2-69	1.7	1.9	1.5
17	Ghadir 33	*NR	Qom	3690	*NR	1.3	1.6	1.1
18	Ansari moghadam 34	2009	Sistan Baluchestan	2587	10-88	2.5	3.2	2.2
19	Salehi 35	*NR	Sistan Baluchestan	3989	6-65	3.38	*NR	*NR
20	Salehi 36	1997	Sistan Baluchestan	410	Min-60	**NE	*NR	*NR
21	Merat 7	2007	Tehran	2327	18-65	2.3	2.7	1.8
22	Sharifi 37	1998	Yazd	576	*NR	6.42	*NR	*NR

^*NR: No Reported

^**NE: No Evaluated